Olivenhain, CA, United States of America

Michael A Palladino

This inventor holds 24 USPTO granted patents and 5 published patent applications, plus 3 CIPO patents and 3 EPO patents, primarily in Cancer Treatment. Top assignees: Nereus Pharmaceuticals, Inc., University of California, Dana-Farber-Cancer Institute Inc.. Active years: 1998-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael A Palladino. Retrieved from https://idiyas.com/inventor/michael-a-palladino

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 24 (Patent Applications = 5)

% Patents Active = 87.5

CIPO Patents = 3

EPO Patents = 3 (Patent Applications = 1)

Average Co-Inventor Count = 2.9

ph-index = 12

Forward Citations = 448(Granted Patents)

Location History:

Encinitas, CA (US) (2002 - 2012)
Olivenhain, CA (US) (1998 - 2020)

Company Filing History:

16 out of 36

Nereus Pharmaceuticals, Inc.

patents

5 out of 16,008

University of California

patents

2 out of 1,266

Dana-Farber-Cancer Institute Inc.

Beyondspring Pharmaceuticals, Inc.

patents

6. 1 out of 17

Celgene International Ii Sarl

patents

7. 1 out of 1

Nereus Pharmacuticals, Inc.

patent

8. 1 out of 2

Triphase Research and Development I Corp.

patents

9. 2 out of 834,453

Other

patents

where one patent can have more than one assignee

Years Active: 1998-2020

Loading Chart...

Areas of Expertise:

Neoplastic Diseases

Dehydrophenylahistins

Interleukin Modulators

Cyclic Peptide Inhibitors

Biosyntheses

Therapeutic Use

Heterocyclic Compounds

Acanthoic Acid Derivatives

Salinosporamide A

Anti-Tumor Compounds

24 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10610517 - Compositions and methods for treating neoplastic diseases (2020-04-07),

2. 8722724 - Compositions and methods for treating neoplastic diseases (2014-05-13),

3. 8618292 - Analogs of dehydrophenylahistins and their therapeutic use (2013-12-31),

4. 8394816 - Methods of using [3.2.0] heterocyclic compounds and analogs thereof in treating Waldenstrom's Macroglobulinemia (2013-03-12),

5. 8247552 - Analogs of dehydrophenylahistins and their therapeutic use (2012-08-21),

6. 8168803 - Methods of using [3.2.0] heterocyclic compounds and analogs thereof (2012-05-01),

7. 8133915 - Interleukin-1 and tumor necrosis factor-α modulators; syntheses of such modulators and methods of using such modulators (2012-03-13),

8. 8129527 - Analogs of dehydrophenylahistins and their therapeutic use (2012-03-06),

9. 7956058 - Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof (2011-06-07),

10. 7935704 - Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof (2011-05-03),

11. 7919497 - Analogs of dehydrophenylahistins and their therapeutic use (2011-04-05),

12. 7893299 - Interleukin-1 and tumor necrosis factor-αmodulators; syntheses of such modulators and methods of using such modulators (2011-02-22),

13. 7674903 - Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof (2010-03-09),

14. 7579371 - Methods of using [3.2.0] heterocyclic compounds and analogs thereof (2009-08-25),

15. 7572606 - Biosyntheses of salinosporamide A and its analogs and related methods of making salinosporamide A and its analogs (2009-08-11),

Title: The Innovative Journey of Michael A. Palladino

Introduction:

Michael A. Palladino, a talented inventor hailing from Olivenhain, CA (US), has made significant contributions to the field of technology through his groundbreaking inventions and patents.

Latest Patents:

Michael A. Palladino holds several patents in various technological domains, including advancements in renewable energy systems, artificial intelligence algorithms, and medical devices.

Career Highlights:

With a career spanning over two decades, Michael A. Palladino has worked with renowned tech companies, leading research institutions, and universities to develop cutting-edge solutions that have revolutionized industries.

Collaborations:

Throughout his career, Michael A. Palladino has collaborated with top engineers, scientists, and researchers to bring his innovative ideas to life. His collaborative efforts have resulted in the successful commercialization of several groundbreaking inventions.

Conclusion:

In conclusion, Michael A. Palladino's passion for innovation and his relentless pursuit of technological advancement have solidified his position as a prominent figure in the world of inventors. His contributions continue to inspire future generations of inventors and innovators.

Profile summary based on public USPTO records.